Pharmacology of interferons I. pharmacologic distinctions between human leukocyte and fibroblast interferons
Authors:
- 1 January 1979
- journal article
- Published by Elsevier in International Journal of Immunopharmacology
- Vol. 1 (3) , 219-226
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Human interferon production with diploid fibroblast cells grown on microcarriersBiotechnology and Bioengineering, 1979
- Human Interferon as a Therapeutic AgentNew England Journal of Medicine, 1979
- Large-scale Production of Human Leukocyte Interferon Containing 108 Units per mlJournal of General Virology, 1978
- NON-APPEARANCE OF INJECTED FIBROBLAST INTERFERON IN CIRCULATIONThe Lancet, 1978
- Interferons: Anti-neoplastic drugs?Annals of Hematology, 1977
- Comparison of Rates of Clearance of Human Fibroblast and Leukocyte Interferon from the Circulatory System of RabbitsThe Journal of Infectious Diseases, 1976
- Distinct Molecular Species of Human Interferons: requirements for Stabilization and Reactivation of Human Leukocyte and Fibroblast InterferonsJournal of General Virology, 1975
- Pronounced antiviral activity of human interferon on bovine and porcine cellsNature, 1974
- Inactivation of Human Interferon by UrineThe Journal of Infectious Diseases, 1973
- Production of High-Titered Interferon in Cultures of Human Diploid CellsAntimicrobial Agents and Chemotherapy, 1972